Feasibility, Tolerance and Efficacy of Interferon-free, Antiviral Treatment With Sofosbuvir + Ribavirin for the Treatment of Genotype 2 and Sofosbuvir/Ledipasvir for the Treatment of Genotype 1 and 4 Hepatitis C Virus-infected Patients in West and Central Africa

NCT02405013 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatitis C
HIV Infection

Interventions

DRUG: Sofosbuvir
DRUG: Ribavirin
DRUG: Sofosbuvir
DRUG: Ledipasvir

Sponsor

ANRS, Emerging Infectious Diseases